The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tikhomirov A.L.

Kazenashev V.V.

Department of Obstetrics and Gynecology, Faculty of General Medicine, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Yudina T.A.

Department of Obstetrics and Gynecology, Faculty of General Medicine, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Flexible extended regimen of the micro-dose COC: the optimization of contraceptive, therapeutic and prophylactic effectiveness

Authors:

Tikhomirov A.L., Kazenashev V.V., Yudina T.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2016;22(5): 129‑132

DOI: 10.17116/repro2016225129-132

Read: 10162 times

Download PDF (RU)
Contact the author
Table of contents

FLEXIBLE EXTENDED REGIMEN OF THE MICRO-DOSE COC: THE OPTIMIZATION OF CONTRACEPTIVE, THERAPEUTIC AND PROPHYLACTIC EFFECTIVENESS
FLEXIBLE EXTENDED REGIMEN OF THE MICRO-DOSE COC: THE OPTIMIZATION OF CONTRACEPTIVE, THERAPEUTIC AND PROPHYLACTIC EFFECTIVENESS

To cite this article:

Tikhomirov AL, Kazenashev VV, Yudina TA. Flexible extended regimen of the micro-dose COC: the optimization of contraceptive, therapeutic and prophylactic effectiveness. Russian Journal of Human Reproduction. 2016;22(5):129‑132. (In Russ.)
https://doi.org/10.17116/repro2016225129-132

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Expe­rience of using ribo­ciclib in the therapy of meta­static breast cancer in a regional onco­logical dispensary. P.A. Herzen Journal of Onco­logy. 2025;(3):89-93
Resu­lts of the inte­rnational multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the effi­cacy and safety of the sequential therapy with ethy­lmethylhydroxypyridine succinate in patients in the acute and early reco­very periods of ischemic stroke (MIR). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):40-53
Costs of home-based respiratory support and oxygen therapy. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):93-102
Resu­lts of manual therapy in dege­nerative spine diseases with and without radi­culopathy. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):47-55
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Resu­lts of an open-label, randomized, multicenter, comparative study of clinical effi­cacy and safety of Pulmibud drug and Pulmicort drug in patients with partially controlled and unco­ntrolled persistent bronchial asthma. Journal of Respiratory Medi­cine. 2025;(3):33-38
Asso­ciations of poly­morphic variants of CYP2C19*2, *17 with effe­ctiveness and safety of sertraline in adolescents with a depressive episode and suicidal tendencies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):12-20
Onasemnogene abeparvovec gene replacement therapy for spinal muscular atro­phy in children: a Moscow expe­rience. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):103-113
Abstract:

High contraceptive effectiveness of the flexible extended regimen of the microdose combined oral contraception in the digital dispenser is represented in the review. Good safety and tolerability of a new regimen is noted.

Keywords:

combined oral contraceptives
drospirenone
flexible extended regimen
digital dispenser
effectiveness
safety

Authors:

Tikhomirov A.L.

Kazenashev V.V.

Department of Obstetrics and Gynecology, Faculty of General Medicine, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Yudina T.A.

Department of Obstetrics and Gynecology, Faculty of General Medicine, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Close metadata

References:

  1. Reif S, Snelder N, Blode H. Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study. J Fam Plann Reprod Health Care. 2013 Apr;39(2):e1-e13. doi: 10.1136/jfprhc-2012-100397
  2. Wiegratz I, Elliesen J, Paoletti AM, Walzer A, Kirsch B. Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study. Int J Womens Health. 2015 Jan 5;7:19-29. doi: 10.2147/IJWH.S71906
  3. Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J. Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012 Apr;38(2):73-83. doi: 10.1136/jfprhc-2011-100213
  4. Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J. Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study. J Fam Plann Reprod Health Care. 2012 Apr;38(2):84-93. doi: 10.1136/jfprhc-2011-100214
  5. Strowitzki T, Kirsch B, Elliesen J. Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012 Apr;38(2):94-101. doi: 10.1136/jfprhc-2011-100225
  6. Jensen JT, Garie SG, Trummer D, Elliesen J. Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study. Contraception. 2012 Aug;86(2):110-118. doi: 10.1016/j.contraception.2011.12.009
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.